Page last updated: 2024-11-07

muristerone a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Muristerone A is a naturally occurring ecdysteroid with a unique structure that differentiates it from other ecdysteroids. It was initially isolated from the plant *Ajuga reptans* and later found in other plant sources like *Cyperus rotundus*. Muristerone A exhibits a wide range of biological activities, including anti-inflammatory, antioxidant, and anticancer effects. It has also shown promise as a potential treatment for neurodegenerative diseases. Its unique structure and diverse biological activities make it a subject of ongoing research interest. Scientists are particularly interested in elucidating its mechanisms of action, exploring its therapeutic potential, and developing synthetic analogs with improved pharmacological properties.'

muristerone A: a phytoecdysteroid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID122217
CHEMBL ID2087139
SCHEMBL ID19419608
MeSH IDM0155854

Synonyms (21)

Synonym
muristerone
2beta,3beta,5beta,11alpha,14alpha,20r,22r-heptahydroxycholest-7-en-6-one
muristerone a
(2s,3r,5s,9r,10r,11r,13r,14s,17s)-17-[(2r,3r)-2,3-dihydroxy-6-methylheptan-2-yl]-2,3,5,11,14-pentahydroxy-10,13-dimethyl-1,2,3,4,9,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-6-one
38778-30-2
2beta,3beta,5beta,11alpha,14alpha,20r,22r-heptahydro xycholest-7-en-6-one
cholest-7-en-6-one, 2,3,5,11,14,20,22-heptahydroxy-, (2beta,3beta,5beta,11alpha,22r)-
CHEMBL2087139
2,3,5,11,14,20,22-heptahydroxycholest-7-en-6-one
(2?,3?,5?,11?,22r)-2,3,5,11,14,20,22-heptahydroxycholest-7-en-6-one
c27h44o8
HB3985
AKOS024457813
5b,7-cholestene-2b,3b,5a,11a,14,20,22-heptol-6-one
bdbm50488539
(2s,3r,5s,9r,10r,11r,13r,14s,17s)-17-((2r,3r)-2,3-dihydroxy-6-methylheptan-2-yl)-2,3,5,11,14-pentahydroxy-10,13-dimethyl-2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-6(10h)-one
SCHEMBL19419608
DTXSID40959583
CS-0026791
HY-103273
mfcd00056450
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
UltraspiracleNezara viridula (southern green stink bug)IC50 (µMol)0.14000.13001.33674.5000AID1111843; AID1111844
UltraspiracleNezara viridula (southern green stink bug)Ki0.10000.10001.01673.0000AID1111843; AID1111844
20-hydroxy-ecdysone receptor Nezara viridula (southern green stink bug)IC50 (µMol)0.14000.13001.33674.5000AID1111843; AID1111844
20-hydroxy-ecdysone receptor Nezara viridula (southern green stink bug)Ki0.10000.10001.01673.0000AID1111843; AID1111844
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID1111843Displacement of [3H]PonA from recombinant Nezara viridula EcR102011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID1111844Displacement of [3H]PonA from recombinant Nezara viridula EcR112011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID683076Inhibition of human ABCB1 pump expressed in mouse L5178 cells assessed as fluorescence activity ratio at 20 uM for 10 mins by flow cytometry relative to control2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (57)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.75)18.7374
1990's20 (35.09)18.2507
2000's30 (52.63)29.6817
2010's6 (10.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 17.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index17.19 (24.57)
Research Supply Index4.11 (2.92)
Research Growth Index6.12 (4.65)
Search Engine Demand Index10.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (17.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other60 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]